REMUNERATION
Changes to Remuneration from October 2015
Establishment Payment
Contractors will receive a one off payment of an additional £50 in November payment if pharmacists, technicians and locums in their employ by the 31st of March have completed the six e-modules on Adverse Drug Reactions. The purpose of these modules are so that pharmacy teams understand the categorisation of ADRs, how to avoid ADRs and promote the completion of Yellow Warning Cards. It is also expected that contractors ensure SOPs are updated to reflect the need to complete Yellow Warning Cards for reported ADRs.
Post payment verification may take place on this one off payment and contractors are encouraged to ensure records of completion are kept.
Public Health Service
The main changes to service delivery for pharmacists are the adoption of ulipristal onto the community pharmacy emergency hormonal contraception scheme and the introduction of a scheme to support the meningitis B vaccination scheme in children.
To support the role out of ulipristal into the community pharmacy scheme pharmacists providing the Emergency Hormonal Contraception will be expected to complete two NHS Education Scotland e -modules.
38 - SCOTTISH PHARMACIST
The first is on contraception and supports training to pharmacists on all types of contraception including emergency contraception. The second module is a module on the important area of child protection and ensures pharmacists are aware of the current legal and ethical framework around child protection.
Scottish Pharmacist spoke with Tony Fraser General Manager, HRA Pharma following the announcement that ulipristal had been included on the EHC scheme. Tony said, “We are delighted that EllaOne is now included in the National Community Pharmacy Public Health Service. ellaOne is the most effective EHC, as well as being very cost effective and this important decision means that women in Scotland now have access to the most effective product from community pharmacy, either through the national scheme or purchase. This is great news for women in Scotland and an innovative step forward for community pharmacy.”
The Public Health Service has also been augmented with a service to support the Meningitis B vaccination scheme. During clinical trials of the Meningitis B vaccine it was noticed that children frequently had elevated temperatures post vaccination. This has led to JCVI recommending that children receive a prophylactic dose of paracetamol prior to vaccination. To support GPs and Health Visitors
providing vaccination community pharmacists have been asked via PGD to supply paracetamol suspension on a CPUS form. Each pharmacy should have sent PGDs for pharmacists to sign to deliver the service.
Operation and Development Payment
This payment ensures that contractors are remunerated for key services around CMS and Gluten Free Prescribing. From October 2015 it has been agreed that following the review of Gluten Free prescribing that all pharmacies will be remunerated at £125 per month for providing the Gluten Free service.
The variable element of the OandD payment is however, more complex and requires contractors to ensure that:
A) 95% of CMS registered patients are risk assessed and set a priority for a care plan
B) An SOP is in place for CMS serial Rx prescribing
C) From 31st
of October the number of New Medicine Service intervention and High Risk Interventions are 7% or greater of CMS registrations.
The key change in this payment is the movement from 5% to 7% of the number of intervention for new
medicines and high risk medicines.
Speaking on the changes Matt Barclay said “'the changes to remuneration from October recognise that access through the pharmacy network offers opportunities in the three key areas of patient care:
1 Medicine Safety –identification of adverse events from medicines and subsequent yellow card reporting
2 Public Health Interventions - changes to the sexual health PGD and Meningitis B vaccination prophylaxis further increase our visibility to support care for patients in all age groups
3 Long-term conditions management – through the continuation of the Gluten Free Prescribing Scheme.
Community Pharmacy Scotland are particularly delighted that the Gluten Free service review concluded positively for community pharmacy teams and demonstrated their ability to impact for the better on patient care in this disease area.
We also welcome the extension of EHC provision to include ulipristal, this is something Community Pharmacy Scotland have long called for and increases pharmacist’s ability to treat more patients’ effectively when accessing the service.” •
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56